Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Celcuity Inc (NQ: CELC )

12.46 -0.20 (-1.58%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Celcuity Inc

< Previous 1 2 3 4 Next >
Earnings Scheduled For November 14, 2024
Via Benzinga
Insights into Celcuity's Upcoming Earnings
Via Benzinga
CELC Stock Earnings: Celcuity Beats EPS for Q2 2024
CELC stock results show that Celcuity beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
CELC Stock Earnings: Celcuity Beats EPS for Q1 2024
CELC stock results show that Celcuity beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
CELC Stock Earnings: Celcuity Beats EPS for Q4 2023
CELC stock results show that Celcuity beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Recap: Celcuity Q4 Earnings
Via Benzinga
Celcuity Earnings Preview
Via Benzinga
Celcuity Inc. Announces $50 Million Private Placement
Via ACCESSWIRE
Preview: Celcuity's Earnings
Via Benzinga
A Preview Of Celcuity's Earnings
Via Benzinga
Celcuity's Earnings: A Preview
Via Benzinga
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
The 7 Best Short-Squeeze Stocks to Buy Now: September 2023
Explore the potential of the best short-squeeze stocks to buy now as companies attempt to prove pessimistic traders wrong. 
Via InvestorPlace
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
A Preview Of Celcuity's Earnings
Via Benzinga
7 Short-Squeeze Stocks That Actually Might Make Sense
Although the concept of short-squeeze stocks is one best left for speculators, these ideas have a touch of rationality behind them. 
Via InvestorPlace
10 Short Squeeze Stocks To Watch: Yellow Corporation, Getty Images, Tupperware And More
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga
Celcuity Set to Join Russell 2000 and 3000 Indexes
Via ACCESSWIRE
Celcuity to Participate in Upcoming Craig-Hallum and Jefferies Investor Conferences
Via ACCESSWIRE
Celcuity Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Updates
Via ACCESSWIRE
Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib in Treatment-Naïve Patients at the 2023 ESMO Breast Cancer Annual Congress
Via ACCESSWIRE
Celcuity Inc. Schedules Release of First Quarter 2023 Financial Results and Webcast/Conference Call
Via ACCESSWIRE
Celcuity to Present Updated Results for Treatment-Naïve Patients from Phase 1b Study of Gedatolisib at the 2023 ESMO Breast Cancer Annual Congress
Via ACCESSWIRE
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023
Via ACCESSWIRE
Celcuity to Participate in 22nd Annual Needham Virtual Healthcare Conference
Via ACCESSWIRE
Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Via ACCESSWIRE
Earnings Scheduled For March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Webcast/Conference Call
Via ACCESSWIRE
Celcuity to Present Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.